πŸ‡ΊπŸ‡Έ FDA
Patent

US 12428415

Matriptase 2 inhibitors and uses thereof

granted A61PA61P1/16A61P3/00

Quick answer

US patent 12428415 (Matriptase 2 inhibitors and uses thereof) held by Disc Medicine, Inc. expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Disc Medicine, Inc.
Grant date
Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61P, A61P1/16, A61P3/00, A61P7/00, A61P7/06